KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lantronix (LTRX) Asset Writedowns and Impairment (2016 - 2018)

Historic Asset Writedowns and Impairment for Lantronix (LTRX) over the last 9 years, with Q1 2018 value amounting to $41000.0.

  • Lantronix's Asset Writedowns and Impairment rose 9523.81% to $41000.0 in Q1 2018 from the same period last year, while for Mar 2018 it was $387000.0, marking a year-over-year increase of 9744.9%. This contributed to the annual value of $275000.0 for FY2019, which is N/A changed from last year.
  • Per Lantronix's latest filing, its Asset Writedowns and Impairment stood at $41000.0 for Q1 2018, which was up 9523.81% from -$125000.0 recorded in Q4 2017.
  • In the past 5 years, Lantronix's Asset Writedowns and Impairment registered a high of $246000.0 during Q3 2017, and its lowest value of -$125000.0 during Q4 2017.
  • Its 5-year average for Asset Writedowns and Impairment is $60235.3, with a median of $41000.0 in 2018.
  • Over the last 5 years, Lantronix's Asset Writedowns and Impairment had its largest YoY gain of 179230.77% in 2017, and its largest YoY loss of 41250.0% in 2017.
  • Quarter analysis of 5 years shows Lantronix's Asset Writedowns and Impairment stood at $5000.0 in 2014, then grew by 20.0% to $6000.0 in 2015, then soared by 566.67% to $40000.0 in 2016, then plummeted by 412.5% to -$125000.0 in 2017, then skyrocketed by 132.8% to $41000.0 in 2018.
  • Its Asset Writedowns and Impairment stands at $41000.0 for Q1 2018, versus -$125000.0 for Q4 2017 and $246000.0 for Q3 2017.